Status:
COMPLETED
Evaluating Patient Information Prescriptions
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Library of Medicine (NLM)
Conditions:
Breast Neoplasms
Premature Birth
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Research shows that patient satisfaction with medical care correlates strongly with how satisfied they are with the ease of getting information from their providers regarding their medical condition. ...
Detailed Description
The goal of this research is to evaluate IRx, to provide enough data so care organizations can decide whether to implement this in their own environment. To that end, our specific aims are: 1. To ev...
Eligibility Criteria
Inclusion
- Breast Cancer: any new patient seen in Johns Hopkins medical oncology for Breast Cancer
- Neonatal Intensive care:Biological mothers (or consenting guardians) of premature infants born and admitted or transferred in to Johns Hopkins Hospital or Bayview Medical Center neonatal intensive care units.
Exclusion
- Breast Cancer: None
- Neonatal Intensive Care: Parents with infants whose SNAP mortality \>= 80%(J Pediatr. 2001 Jan;138(1):92-100)
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
299 Patients enrolled
Trial Details
Trial ID
NCT00355381
Start Date
September 1 2004
End Date
September 1 2009
Last Update
October 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins School of Medicine
Baltimore, Maryland, United States, 21205